1. Home
  2. KEQU vs CGEN Comparison

KEQU vs CGEN Comparison

Compare KEQU & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

HOLD

Current Price

$39.07

Market Cap

124.6M

Sector

Industrials

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$1.50

Market Cap

143.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
CGEN
Founded
1906
1993
Country
United States
Israel
Employees
N/A
74
Industry
Medical Specialities
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
124.6M
143.1M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
KEQU
CGEN
Price
$39.07
$1.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.3K
295.7K
Earning Date
12-10-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.94
N/A
Revenue
$285,515,000.00
$6,903,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$231.15
P/E Ratio
$9.59
N/A
Revenue Growth
43.02
N/A
52 Week Low
$30.33
$1.13
52 Week High
$71.33
$2.66

Technical Indicators

Market Signals
Indicator
KEQU
CGEN
Relative Strength Index (RSI) 47.32 41.43
Support Level $37.50 $1.47
Resistance Level $41.04 $1.72
Average True Range (ATR) 1.44 0.08
MACD 0.22 -0.00
Stochastic Oscillator 51.45 12.00

Price Performance

Historical Comparison
KEQU
CGEN

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: